Primary dural high grade B cell lymphoma mimicking subdural hematoma

QR Code

Primary dural high grade B cell lymphoma mimicking subdural hematoma

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Aya Nakaya, Kazuyoshi Ishii, Shosaku Nomura
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/267a830e2f3e4be1ae592b2e5b5885d7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

THE SMALLEST PRIMARY BONE LYMPHOMA
par: Fatma Burçin KURTİPEK, et autres
Publié: (2021)

A CASE OF MULTI REGIONAL PRIMARY MUSCLE LYMPHOMA
par: Beyza OLUK, et autres
Publié: (2021)

PROGNOSIS FACTORS IN AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH PRIMARY INVOLVEMENT OF THE SPLEEN
par: Larisa Musteata, et autres
Publié: (2021)

CAVITARY PRIMARY PULMONARY LYMPHOPLASMOCYTIC LYMPHOMA COMPLICATING HENOCH–SCHÖNLEIN PURPURA
par: Burak GULTEKIN, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

CLINICAL CHARACTERISTICS, AND SURVIVAL RATE OF ELDERLY PATIENTS WITH NON-HODGKIN'S LYMPHOMAS WITH PRIMARY INVOLVEMENT OF PERIPHERAL LYMPH NODES
par: Tomacinschii Victor, et autres
Publié: (2021)

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
par: Farina F, et autres
Publié: (2014)

Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
par: John R. Krause, et autres
Publié: (2021)

Advances in the diagnosis and management of lymphoma
par: Matasar MJ, et autres
Publié: (2012)

MEDICAL TREATMENT IN HODGKIN LYMPHOMA
par: Nilgun Kurucu
Publié: (2021)

MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015)

ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA
par: Sanda Buruiana, et autres
Publié: (2021)

Peripheral T cell lymphoma: clinical utility of romidepsin
par: Sawey K, et autres
Publié: (2012)

Preserving fertility in young patients with lymphoma: an overview
par: Patel B, et autres
Publié: (2014)

MicroRNAs as B-cell lymphoma biomarkers
par: Manterola L, et autres
Publié: (2015)

Mogamulizumab for the treatment of adult T-cell leukemia/lymphoma
par: Yoshimitsu M, et autres
Publié: (2014)

THREE CASES WITH BURKITT LYMPHOMA PRESENTING WITH CHOLESTASIS
par: Fatma Tuba YILDIRIM, et autres
Publié: (2021)

CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX
par: Senem MARAL, et autres
Publié: (2021)

Emerging role of SOX11 in mantle cell lymphoma
par: Kuci V, et autres
Publié: (2015)

A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
par: Pınar Tığlıoğlu, et autres
Publié: (2021)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
par: McKinney MS, et autres
Publié: (2014)

Emerging targets in human lymphoma: targeting the MYD88 mutation
par: Wang JQ, et autres
Publié: (2013)

BURKITT LYMPHOMA PRESENTING WITH EYE AND KIDNEY INVOLVEMENT: CASE REPORT
par: Aslı Turgutoğlu Yılmaz, et autres
Publié: (2021)

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
par: Ebru Pekgüç, et autres
Publié: (2021)

UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT
par: Carlos CHIATTONE, et autres
Publié: (2021)

Monomorphic epitheliotropic intestinal T-cell lymphoma of the duodenum: an aggressive disease
par: Ganesh Kasinathan
Publié: (2021)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)

Reduced intensity treatment in early-stage Hodgkin&rsquo;s lymphoma
par: Armitage JO, et autres
Publié: (2011)

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
par: Illidge T, et autres
Publié: (2012)

THE EFFECT OF COMORBIDITY AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MARGINAL ZONE LYMPHOMA
par: Esra TURAN ERKEK, et autres
Publié: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
par: Moormann AM, et autres
Publié: (2014)

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future
par: Flowers CR, et autres
Publié: (2012)

mTOR inhibitor in the treatment of Hodgkin&rsquo;s lymphoma: a case report
par: Provencio M., et autres
Publié: (2011)

CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER
par: Mesut Tığlıoğlu, et autres
Publié: (2021)

Splenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management
par: Teixeira Mendes LS, et autres
Publié: (2014)

HIGH GRADE GLIOMA OF CENTRAL NERVOUS SYSTEM: SINGLE CENTER TREATMENT EXPERIENCE
par: Nur OLGUN, et autres
Publié: (2021)

CONSTITUTIONAL MISSMATCH DEFECT REPAIR DISORDER (CMMRD) IN PEDIATRIC HIGH GRADE GLIOMA
par: Bahattin Tanrıkulu, et autres
Publié: (2021)